After applying eligibility criteriaincluding documented weight reduction within one year prior to fertility treatment, no history of bariatric surgery or prior pregnancy, complete BMI data and no use of other anti-obesity medications (liraglutide, exenatide, dulaglutide, orlistat)eligible patients were stratified into three BMI categories: overweight (25.029.9 kg/m), obese class I (30.034.9 kg/m), and obese class IIIII ( 35.0 kg/m)
Research found that patients prescribed tirzepatide who actively participated in Voys science-backed programme achieved an average weight loss of 22% after 11 months
The primary endpoint was the classic three-point MACE cardiovascular death, heart attack, or stroke
Non-Waivable Rights Nothing in this policy excludes, limits, or waives a warranty, remedy, or consumer right that cannot lawfully be excluded, limited, or waived
Vic t vn vi bc s xc nh liu b sung Glutathione c ph hp vi c th ca mnh hay khng l cn thit
Most patients notice appetite suppression and early satiety within 2 to 4 weeks of beginning treatment